remodeling old drugs for new ones ¶
By: Jason E. Barkeloo on June 6, 2018, 3:12 p.m.
Remodeling legacy antibiotics for new drugs that fight emerging antibiotic-resistant bacteria.
https://www.nature.com/articles/s41467-017-02123-w
Jason E. Barkeloo
Chairman & Founder, Open Therapeutics
